VIM
JAZZ icon

Vinva Investment Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Vinva Investment Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.98M Buy
11,142
+7,043
+172% +$1.23M 0.04% 250
2025
Q4 		$1.04M Buy
+4,099
New +$628K 0.01% 302
2025
Q3 		– Sell
-2,928
Closed -$480K – 445
2025
Q2 		$480K Buy
2,928
+1,470
+101% +$160K 0.01% 356
2025
Q1 		$285K Sell
1,458
-1,439
-50% -$188K 0.01% 358
2024
Q4 		$573K Buy
2,897
+1,311
+83% +$155K 0.02% 341
2024
Q3 		$254K Buy
+1,586
New +$174K 0.01% 402
2024
Q2 		– Sell
-1,704
Closed -$205K – 435
2024
Q1 		$205K Hold
1,704
– – 0.01% 410
2023
Q4 		$210K Sell
1,704
-681
-29% -$85K 0.01% 388
2023
Q3 		$313K Buy
2,385
+440
+23% +$58.6K 0.03% 331
2023
Q2 		$241K Sell
1,945
-546
-22% -$73.5K 0.02% 358
2023
Q1 		$361K Buy
+2,491
New +$368K 0.03% 348

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Vinva Investment Management's JAZZ Position: Q1 2026 in Review

Vinva Investment Management increased its Jazz Pharmaceuticals (JAZZ) stake by 172% in Q1 2026, buying an estimated $1.23M and bringing the position to 11,142 shares worth $2.98M. The position accounts for 0.04% of the portfolio, ranked #250.

Vinva Investment Management first reported a position in JAZZ in Q1 2023 and has held it in 11 quarters since. 572 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Vinva Investment Management held 11,142 shares of Jazz Pharmaceuticals worth $2.98M as of Q1 2026.
  • Vinva Investment Management bought 7,043 Jazz Pharmaceuticals shares in Q1 2026, an estimated $1.23M.
  • Jazz Pharmaceuticals made up 0.04% of Vinva Investment Management's portfolio in Q1 2026, its #250 holding.
  • Vinva Investment Management first reported a position in Jazz Pharmaceuticals in Q1 2023 and has held it in 11 quarters since.
  • 572 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Vinva Investment Management's 13F filing for Q1 2026, filed 14 May 2026.